CHENGDU, China, July 11, 2019 /PRNewswire/ -- On July 10th, Chengdu Hi-tech Zone and Gilead Sciences inked a strategic cooperation agreement on the Gilead Sciences Western China Operation Center project, which marked the official registration of its western China operation center in Chengdu Hi-tech Zone.

MANHASSET, N.Y., July 10, 2019 /PRNewswire/ -- Theodoros Zanos, PhD, head of the Ne

AQUEBOGUE, N.Y., July 10, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold at CVS Health  the during the time period as indicated in the tables below.  As a precautionary measure, Altaire is voluntarily initiating the recall due to man

NEW YORK, July 10, 2019 /PRNewswire/ -- Aflac Global Investments announced today that it has hired Stephen Scott as managing director; chief financial officer of Aflac Global Investments, reporting to Eric M. Kirsch, executive vice president and global chief investment officer of Aflac Incorporated and preside

CLEVELAND, July 10, 2019 /PRNewswire/ -- Global healthcare expenditures are projected to rise 3.7% annually in real (inflation-adjusted) US dollars through 2023, according to Global Healthcare, a report recently released by Freedonia Focus Reports. Spending will be driven by increasing access to a myriad of healthcare services in low and middle income

NEW HAVEN, Conn., July 10, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), announced today that positive results from a Phase 3 pivotal clinical trial of rimegepant, Biohaven's small molecule calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine, are published in the Jul

BRONX, N.Y., July 10, 2019 /PRNewswire/ -- A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in the July 11 issue of The New England Journal of Medicine. The drug, rimegepant, is awaiting U.S. Fo

EMERYVILLE, Calif., July 10, 2019 /PRNewswire/ -- Canopy Health is pleased to announce the appointment of Chandra Welsh as its new Chief Network Development Officer and member of the leadership team effective Monday, July 15, 2019. 

FRANKLIN, Tenn., July 10, 2019 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, August 6, 2019, after the market closes, it will report results for the second quarter of 2019.  On August 7, 2019, at 9:00 a.m. Cen

WASHINGTON, July 10, 2019 /PRNewswire/ -- Today the President signed an executive order and announced a series of initiatives under the title Advancing American Kidney Health; however, several provisions will benefit the 13,192 liver patients waiting for transplant. Seventeen hundred liver patients die waiting each year.Key measures include calling for increased t